Objective There are no identified clinical markers that reliably predict long‐term progression
of interstitial lung disease (ILD) in systemic sclerosis (SSc; scleroderma). Elevated C‐…

Objective An international multidisciplinary initiative, jointly supported by the American College
of Rheumatology and European Alliance of Associations for Rheumatology, is underway …

Objective To examine the prevalence of isolated IgA anti–β 2 ‐glycoprotein I (anti‐β 2 GPI)
positivity and the association of these antibodies, and a subgroup that bind specifically to …

Objective To measure interferon (IFN)–inducible chemokines in the plasma of patients with
systemic sclerosis (SSc) and investigate whether the chemokine levels are correlated with …

Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms,
functional impairments, and a substantial impact on quality of life. This condition is initially …

Immune regulatory dysfunction, circulating immune complexes (CIC), and polymorphonuclear
(PMN) cell migration were investigated in patients with Behçet's syndrome. Six patients …

Anti-MDA5 (Melanoma differentiation-associated protein 5) myositis is a rare subtype of
dermatomyositis (DM) characterized by distinct ulcerative, erythematous cutaneous lesions and …

Objective The first genome-wide association study (GWAS) of systemic sclerosis (SSc)
demonstrated three non-major histocompatibility complex (MHC) susceptibility loci. The goal of …

Objective To determine if proinflammatory and prothrombotic biomarkers are differentially
upregulated in persistently antiphospholipid antibody (aPL)-positive patients, and to examine …

Objective To examine the predictive role of HLA genetic markers in scleroderma renal crisis
(SRC), beyond the known clinical correlates, in a large population of patients with systemic …